SCHEMBL17457112

SCHEMBL17457112

CCO[Si](CCCOc1ccc(C(=O)c2ccc(/C=C/C(=O)OC)cc2)cc1)(OCC)OCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.47
MAOB P27338 7/20 0.46
SAE1 Q9UBE0 1/20 0.45
UBA2 Q9UBT2 1/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPT P10636 1/20 0.45
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
TYR P14679 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17457113 1.00 ABCG2 (0.47) ABCG2MAOBSAE1UBA2KDM4E
SCHEMBL17457071 0.96 ABCG2 (0.46) ABCG2MAOBSAE1UBA2KDM4E
SCHEMBL17457070 0.96 ABCG2 (0.46) ABCG2MAOBSAE1UBA2KDM4E
SCHEMBL17061317 0.94 CA12 (0.48) ABCG2MAOBSAE1UBA2KDM4E
SCHEMBL17061315 0.94 CA12 (0.48) ABCG2MAOBSAE1UBA2KDM4E
SCHEMBL17457111 0.91 CA12 (0.49) ABCG2MAOBSAE1UBA2CA12
SCHEMBL17457110 0.91 CA12 (0.49) ABCG2MAOBSAE1UBA2CA12
SCHEMBL17457041 0.90 CA12 (0.46) ABCG2MAOBSAE1UBA2KDM4E
SCHEMBL17457055 0.90 ABCG2 (0.47) ABCG2MAOBSAE1UBA2KDM4E
SCHEMBL17457042 0.90 CA12 (0.46) ABCG2MAOBSAE1UBA2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9823401-B2 Cured film formation composition, orientation material, and retardation material NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-11-21 US disclosed
US-9529132-B2 Cured film formation composition, orientation material, and retardation material NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-12-27 US disclosed
US-20160291412-A1 CURED FILM FORMATION COMPOSITION, ORIENTATION MATERIAL, AND RETARDATION MATERIAL NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-10-06 US disclosed
US-20160025915-A1 CURED FILM FORMATION COMPOSITION, ORIENTATION MATERIAL, AND RETARDATION MATERIAL NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-01-28 US disclosed
CN-105051133-A Composition for forming cured film, alignment material, and phase difference material NISSAN CHEMICAL IND LTD 2015-11-11 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160025915-A1 CURED FILM FORMATION COMPOSITION, ORIENTATION MATERIAL, AND RETARDATION MATERIAL CCNA1, RAD51, SMC1A ABCG2 4589/4885MAOB 1530/4885SAE1 2241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.